致力于开发中国双抗疗法的生物技术公司武汉友芝友生物于香港联交所主板正式挂牌
Sep 25, 2023 12:47 HKT |  |
|
致力於開發中國雙抗療法的生物技術公司武漢友芝友生物於香港聯交所主板正式掛牌
Sep 25, 2023 12:46 HKT | |
|
A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK
Sep 25, 2023 12:45 HKT | |
|
Sirnaomics集团入驻香港科学园 共创香港生物医药发展新篇章
Sep 21, 2023 16:49 HKT |  |
|
Sirnaomics集團入駐香港科學園 共創香港生物醫藥發展新篇章
Sep 21, 2023 16:48 HKT | |
|
Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery
Sep 19, 2023 21:00 HKT |  |
|
CGFNS Appoints New Chief Technology Officer to Lead its Digital Transformation
Sep 15, 2023 09:00 HKT |  |
|
Vegan Cats Challenge Carnivorous Expectations
Sep 15, 2023 08:00 HKT |  |
|
专注于中国双抗的开发 武汉友芝友生物宣布于港交所主板上市计划
Sep 13, 2023 11:32 HKT | |
|
專注於中國雙抗的開發 武漢友芝友生物宣佈於港交所主板上市計劃
Sep 13, 2023 11:31 HKT | |
|
Focusing on the development of BsAbs in China, YZY Biopharma Announces Proposed Listing on the Main Board of SEHK
Sep 13, 2023 11:30 HKT | |
|
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
Sep 12, 2023 20:00 HKT |  |
|
中国抗体SM17新药研究申请再获国家药监局批准
Sep 12, 2023 09:50 HKT |  |
|
中國抗體SM17新藥研究申請再獲國家藥監局批准
Sep 12, 2023 09:49 HKT | |
|
SinoMab's IND Application of SM17 has once again Received Approval from NAMP
Sep 12, 2023 09:48 HKT | |
|
Q&M Dental Group Sets the Gold Standard for Best Investor Relations at Singapore Corporate Awards
Sep 11, 2023 10:00 HKT |  |
|
透云生物率先实现工业化量产莱茵衣藻
Sep 07, 2023 13:18 HKT |  |
|
透雲生物率先實現工業化量產萊茵衣藻
Sep 07, 2023 13:17 HKT | |
|
UroViu Corporation Appoints Ali Amiri as New President and Chief Operating Officer
Sep 06, 2023 21:00 HKT |  |
|
Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals
Aug 29, 2023 13:00 HKT |  |
|